Moxifloxacin Pharmacokinetic Profile and Efficacy Evaluation in Empiric Treatment of Community-Acquired Pneumonia

When antimicrobials are used empirically, pathogen MICs equal to clinical breakpoints or epidemiological cutoff values must be considered. This is to ensure that the most resistant pathogen subpopulation is appropriately targeted to prevent emergence of resistance. Accordingly, we determined the pha...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Antimicrob Agents Chemother
Huvudupphovsmän: Öbrink-Hansen, Kristina, Hardlei, Tore Forsingdal, Brock, Birgitte, Jensen-Fangel, Søren, Kragh Thomsen, Marianne, Petersen, Eskild, Kreilgaard, Mads
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology 2015
Ämnen:
Clinical Therapeutics
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4356773/
https://ncbi.nlm.nih.gov/pubmed/25666151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.04659-14
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk